142 related articles for article (PubMed ID: 20472416)
1. Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infection.
McDonald SA; Hutchinson SJ; Bird SM; Robertson C; Mills PR; Dillon JF; Goldberg DJ
Int J Drug Policy; 2011 Jan; 22(1):63-9. PubMed ID: 20472416
[TBL] [Abstract][Full Text] [Related]
2. The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population.
McDonald SA; Hutchinson SJ; Mills PR; Bird SM; Cameron S; Dillon JF; Goldberg DJ
J Viral Hepat; 2011 Apr; 18(4):e126-33. PubMed ID: 20964793
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population.
McDonald SA; Hutchinson SJ; Mills PR; Bird SM; Robertson C; Dillon JF; Springbett A; Goldberg DJ
Epidemiol Infect; 2010 Mar; 138(3):393-402. PubMed ID: 19723361
[TBL] [Abstract][Full Text] [Related]
4. The association between alcohol use and hepatitis C status among injecting drug users in Glasgow.
O'Leary MC; Hutchinson SJ; Allen E; Palmateer N; Cameron S; Taylor A; Goldberg DJ
Drug Alcohol Depend; 2012 Jun; 123(1-3):180-9. PubMed ID: 22137645
[TBL] [Abstract][Full Text] [Related]
5. Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland.
Hutchinson SJ; Bird SM; Goldberg DJ
Hepatology; 2005 Sep; 42(3):711-23. PubMed ID: 16116637
[TBL] [Abstract][Full Text] [Related]
6. Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow.
McDonald SA; Hutchinson SJ; Cameron SO; Innes HA; McLeod A; Goldberg DJ
Int J Drug Policy; 2012 Sep; 23(5):353-7. PubMed ID: 22421553
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.
Roy KM; Hutchinson SJ; Wadd S; Taylor A; Cameron SO; Burns S; Molyneaux P; McIntyre PG; Goldberg DJ
Epidemiol Infect; 2007 Apr; 135(3):433-42. PubMed ID: 16893486
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection in Scotland: epidemiological review and public health challenges.
Hutchinson SJ; Roy KM; Wadd S; Bird SM; Taylor A; Anderson E; Shaw L; Codere G; Goldberg DJ
Scott Med J; 2006 May; 51(2):8-15. PubMed ID: 16722130
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
[TBL] [Abstract][Full Text] [Related]
10. Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: a systematic review.
Corson S; Greenhalgh D; Palmateer N; Weir A; Hutchinson S
Int J Drug Policy; 2011 Mar; 22(2):102-8. PubMed ID: 21112759
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a general practice based hepatitis C virus screening intervention.
Anderson EM; Mandeville RP; Hutchinson SJ; Cameron SO; Mills PR; Fox R; Ahmed S; Taylor A; Spence E; Goldberg DJ
Scott Med J; 2009 Aug; 54(3):3-7. PubMed ID: 19728405
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J
Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection among a cohort of Victorian injecting drug users.
Crofts N; Hopper JL; Bowden DS; Breschkin AM; Milner R; Locarnini SA
Med J Aust; 1993 Aug; 159(4):237-41. PubMed ID: 7692222
[TBL] [Abstract][Full Text] [Related]
14. High hepatitis C incidence in new injecting drug users: a policy failure?
Maher L; Li J; Jalaludin B; Chant KG; Kaldor JM
Aust N Z J Public Health; 2007 Feb; 31(1):30-5. PubMed ID: 17333606
[TBL] [Abstract][Full Text] [Related]
15. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
Solomon SS; Srikrishnan AK; Mehta SH; Vasudevan CK; Murugavel KG; Thamburaj E; Anand S; Kumar MS; Latkin C; Solomon S; Celentano DD
J Acquir Immune Defic Syndr; 2008 Nov; 49(3):327-32. PubMed ID: 18845962
[TBL] [Abstract][Full Text] [Related]
17. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
Miller M; Mella I; Moi H; Eskild A
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):373-9. PubMed ID: 12843749
[TBL] [Abstract][Full Text] [Related]
18. Current Burden of Hepatitis C Virus Infection Among Injecting Drug Users: A Mini Systematic Review of Prevalence Studies.
Rafiq SM; Banik GR; Khan S; Rashid H; Khandaker G
Infect Disord Drug Targets; 2014; 14(2):93-100. PubMed ID: 25313101
[TBL] [Abstract][Full Text] [Related]
19. Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage study.
McDonald SA; Hutchinson SJ; Bird SM; Mills PR; Robertson C; Dillon JF; Williams T; Goldberg DJ
Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):49-57. PubMed ID: 19773667
[TBL] [Abstract][Full Text] [Related]
20. Estimating the number of injecting drug users in Scotland's HCV-diagnosed population using capture-recapture methods.
McDonald SA; Hutchinson SJ; Schnier C; McLeod A; Goldberg DJ
Epidemiol Infect; 2014 Jan; 142(1):200-7. PubMed ID: 23522183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
